Target intelligence / Profile preview

Lipophilic toxicants

Molecular classification
Other
01

Overview

Lipophilic toxicants represent a broad class of hydrophobic chemical substances, including persistent organic pollutants (POPs) such as dioxins, polychlorinated biphenyls (PCBs), and organochlorine pesticides, that preferentially accumulate in the adipose tissue of living organisms (NIH/PubMed, PMID: 24075211). These substances are characterized by high lipid solubility and significant resistance to environmental and metabolic degradation, allowing them to persist in the human body for years or even decades (WHO, 2010). Their presence is linked to a variety of adverse health outcomes, including endocrine disruption, developmental neurotoxicity, and increased cancer risk, primarily through their interaction with intracellular receptors like the Aryl hydrocarbon receptor (AhR) or through the induction of oxidative stress (PubMed, PMID: 28245917). While not a 'therapeutic target' in the traditional sense of a specific protein or enzyme, they are the focus of clinical detoxification strategies that utilize sequestering agents such as non-absorbable lipids or intravenous lipid emulsions to accelerate their clearance and prevent reabsorption (StatPearls, NBK549767). A major clinical challenge involves the mobilization of these toxicants from fat stores into the systemic circulation during periods of rapid weight loss or physiological stress, which can lead to acute symptomatic toxicity (PubMed, PMID: 21062098).

Other names
Persistent organic pollutantsPOPsFat-soluble toxinsLipophilic environmental contaminantsOrganohalogens
02

Mechanism of action

Sequestration and enhancement of fecal excretion via the interruption of enterohepatic circulation or the creation of a systemic lipid sink to redistribute toxins away from target organs.

03

Biological functions

BioaccumulationBiomagnificationEndocrine disruptionOxidative stress induction
04

Disease associations

CancerEndocrine disordersNeurotoxicityReproductive toxicityMetabolic syndrome
05

Safety considerations

Redistribution and acute toxicity during rapid weight lossLong-term bioaccumulation in adipose tissueEnterohepatic recirculationTransgenerational transfer via breast milk
06

Interacting drugs

Intravenous lipid emulsion

4 more in the full profile.

07

Biomarkers

Serum pollutant levelsAdipose tissue biopsy concentrationCytochrome P450 (CYP1A1) induction

Beyond the preview

Go deeper on Lipophilic toxicants.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipophilic toxicants.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call